EQUITY ALERT: Rosen Law Firm Announces Investigation of TriVascular Technologies, Inc. Concerning its Proposed Sale to Endolo...
29 October 2015 - 7:33AM
Business Wire
Rosen Law Firm, a global investor rights law firm, announces
that it is investigating the Board of Directors of TriVascular
Technologies, Inc. (NASDAQ:TRIV) for possible breaches of fiduciary
duty and other violations of law by failing to adequately shop
TriVascular Technologies to maximize shareholder value before
agreeing to be acquired by Endologix, Inc. (NASDAQ:ELGX).
If you would like to join the action, go to the firm’s website
at http://rosenlegal.com/cases-765.html or contact Phillip Kim or
Kevin Chan toll-free at 866-767-3653 or via e-mail at
pkim@rosenlegal.com or kchan@rosenlegal.com. There is no cost or
obligation to you.
Under the terms of the proposed transaction, shareholders will
receive a combination of cash and stock to be determined at the
closing of the merger, which is currently valued at approximately
$9.10 per share. The proposed transaction is valued at
approximately $211 million. The investigation relates to whether
the proposal is fair to the public shareholders of TriVascular
Technologies and whether TriVascular Technologies’ Board breached
its fiduciary duties in connection with the proposed sale.
If you currently own shares of TriVascular Technologies and wish
to obtain additional information, please visit the firm’s website
at http://rosenlegal.com/cases-765.html. You may also contact
Phillip Kim or Kevin Chan of Rosen Law Firm toll free at
866-767-3653 or via e-mail at pkim@rosenlegal.com or
kchan@rosenlegal.com.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151028006752/en/
The Rosen Law Firm, P.A.Phillip Kim, Esq.Kevin Chan,
Esq.Laurence Rosen, Esq.275 Madison Avenue, 34th FloorNew York, NY
10016Tel: 212-686-1060Toll Free: 1-866-767-3653Fax:
212-202-3827pkim@rosenlegal.comkchan@rosenlegal.comlrosen@rosenlegal.comwww.rosenlegal.com
TRIVASCULAR TECHNOLOGIES, INC. (NASDAQ:TRIV)
Historical Stock Chart
From Oct 2024 to Nov 2024
TRIVASCULAR TECHNOLOGIES, INC. (NASDAQ:TRIV)
Historical Stock Chart
From Nov 2023 to Nov 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Trivascular Technologies, Inc. (MM) News Articles